Media Release: TYSONS, Va. and CARRICK ON SHANNON, Ireland, Sept. 28, 2017 (via GLOBE NEWSWIRE)
Cora Systems, a leading global provider of enterprise portfolio, program and project management (EPPM) solutions, has been named a finalist in the 2017 Pharma Industry Awards. Cora has been honoured with the finalist designation in the “Pharma Supplier of the Year” category.
The category winner will be announced at a ceremony on October 5th at the Clayton Hotel, Burlington Road, Dublin.
The annual awards program is presented in association with Kuehne + Nagel’s Pharma and Healthcare Division.
“We are extremely honored to have been singled out as a finalist in this prestigious awards program,” said Philip Martin, Founder and Chief Executive Officer of Cora Systems. “Our professional services teams and our EPPM software solution, ProjectVision, have been instrumental in helping pharmaceutical companies of all sizes drive successful outcomes for their projects.”
ProjectVision, Cora’s customised EPPM solution, is an intuitive web-based tool that offers specific benefits to the pharmaceutical industry such as process compliance, risk management, and project cost savings through Lean Management programs. In addition to the software, Cora’s professional services teams provide mentoring to achieve solution ROI in six months or less. Additionally, Cora’s flexible approach provides a customisable solution that fits seamlessly into existing methodologies and practices, eliminating costly and time-consuming re-training.
About Cora Systems
Cora Systems provides EPPM solutions and services to government agencies and large-scale global organisations, including life sciences, healthcare, and engineering & construction. Every day, thousands of project managers across the world use the Cora platform to manage their portfolio of projects, totalling over $ 10 billion in value, across multiple locations, dozens of countries and thousands of users. Headquartered in Ireland and with regional offices in Washington, DC and London (UK), Cora’s client roster includes Allergan, Boston Scientific and Eli Lilly.
Originally posted on Globe News Wire